RNAi

December 14, 2023 R&D Day 2023 Recap: Following the Science to Deliver on the Promise of RNAi Therapeutics During our 2023 R&D Day, our leadership discussed several exciting innovations and provided a look ahead at the rapid growth and evoltuion of our pipeline. Read More ›
August 9, 2023 RNAi Therapeutics on the European Pharmaceutical Review Podcast Paul Nioi, PhD, VP of Discovery and Translational Research discussed RNAi therapeutics on the The European Medical Review Podcast. Read More ›
March 16, 2023 Alnylam's Paul Nioi, PhD on The Genetics Podcast: Using Genetics in Drug Target Discovery Paul Nioi, PhD, VP of Discovery and Translational Research and Head of Alnylam Human Genetics recently spoke with Dr. Patrick Short on The Genetics Podcast. Read More ›
March 10, 2023 Harnessing Human Genetics to Power the Next Wave of RNAi Therapeutics Learn about how Alnylam's approach to genetic validation and how it is using genetics to power the development of the next wave of RNAi therapeutics Read More ›
February 4, 2022 Alnylam Receives Prestigious Massachusetts Economic Impact Award We are pleased and honored to have been named a Gold Team Massachusetts Economic Impact Award winner for 2022 by MassEcon. Read More ›
May 1, 2020 John Maraganore on the "I Am BIO" Podcast: Destroying COVID's Genome Our CEO John Maraganore recently spoke with Biotechnology Innovation Organization (BIO) CEO and Chairman Jim Greenwood on the "I Am BIO" podcast. Read More ›
October 1, 2019 The Importance of Ensuring Quality in a New Class of Medicines In Product Quality, we have a truly big picture view of the medicines we’re making to ensure they are compliant with good manufacturing practices and... Read More ›
October 1, 2019 Building for Our Future Why would a company without a commercially approved medicine decide to build a significant manufacturing facility? Why not continue to rely on contract... Read More ›
September 2, 2019 ORION-11: A Landmark Event for RNAi Therapeutics The results from the ORION-11 Phase 3 study of inclisiran, presented earlier today at the European Society of Cardiology meeting represent a landmark event... Read More ›
May 12, 2019 What is RNAi and How Do RNAi Therapeutics Work? What is RNAi? This video explains how Alnylam is leading the translation of RNAi to create an entirely new class of innovative medicines to treat disease. Read More ›

Get In Touch

Have any questions or comments about the content you see on this page?

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site